Intolerance of oral methotrexate in juvenile idiopathic arthritis
Two-thirds of patients experienced AEs with oral MTX, leading some to fail remission and require biologics. Intolerability of oral MTX was common and significantly influenced patient outcomes.
Authors
- Ryoki Hara
- Kenichi Nishimura (ORCID: https://orcid.org/0000-0002-9827-3503)
- Ana Yuda (ORCID: https://orcid.org/0009-0004-4252-3106)
- Seira Hattori (ORCID: https://orcid.org/0000-0002-4414-7720)
- Tomo Nozawa (ORCID: https://orcid.org/0000-0002-7072-0463)
- Shuichi Ito (ORCID: https://orcid.org/0000-0002-5242-8987)
- Ayako Murase
Institutions
- National Hospital Organization (JP)
- Nagasaki University Hospital (JP)
- Yokohama City University (JP)
Publication Details
- Journal
- Pediatrics International
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1111/ped.70112
- Citations
- 1
- Primary Topic
- Autoimmune and Inflammatory Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 1.77